# CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer

> **NCT00643318** · PHASE2 · UNKNOWN · sponsor: **Accuray Incorporated** · enrollment: 40 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **RADIATION:** CyberKnife Stereotactic Radiosurgery

## Key facts

- **NCT ID:** NCT00643318
- **Lead sponsor:** Accuray Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-04
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00643318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00643318, "CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00643318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*